Nabi Biopharmaceuticals (NABI) Effects Reverse Stock Split and Announces the Completion of and Final Exchange Ratio for the Business Combination Transaction With Biota Holdings Limited (BTA.AX)
11/9/2012 9:51:12 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Nabi Stockholder Meeting Results and the Approval of the Business Combination Transaction by Biota Holdings Limited (BTA.AX) Stockholders
10/24/2012 8:45:26 AM
More...
|
Biota Holdings Limited (BTA.AX) Announces Approval of Definitive Merger Agreement by Nabi Biopharmaceuticals (NABI) Shareholders
10/23/2012 8:46:40 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Exchange Ratio for Proposed Business Combination Transaction With Biota Holdings Limited (BTA.AX)
10/19/2012 8:46:51 AM
More...
|
Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceuticals (NABI) Stockholders Support Amended Transaction With Biota Holdings Limited (BTA.AX) at October 22nd Reconvened Special Meeting
10/16/2012 9:39:17 AM
More...
|
Biota Holdings Limited (BTA.AX) in Advanced Discussions With Russell H. Plumb to Assume Role of President and CEO of Biota Pharmaceuticals, Inc.
9/7/2012 10:04:21 AM
More...
|
Biota Holdings Limited (BTA.AX) Shareholders Meeting on Proposed Merger With Nabi Biopharmaceuticals (NABI)
8/10/2012 9:40:35 AM
More...
|
Biota Holdings Limited (BTA.AX) Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention Study Update
5/14/2012 8:08:21 AM
More...
|
Nabi Biopharmaceuticals (NABI) Merges With Biota Holdings Limited (BTA.AX) to Create a $250 Million Group; Biota to Move to the US
4/23/2012 7:19:57 AM
More...
|
AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited (BTA.AX)
4/17/2012 10:01:43 AM
More...
|
|